Safety and feasibility of acute percutaneous septal sinus shortening: First‐in‐human experience
- 23 February 2007
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 69 (4), 513-518
- https://doi.org/10.1002/ccd.21070
Abstract
Background: Multiple percutaneous therapies for the treatment of functional and ischemic mitral regurgitation (FMR/IMR) are under development. We previously reported a novel percutaneous technique, the percutaneous septal sinus shortening [PS3] System™, which was effective in ameliorating FMR in an animal model. We herein report results from the first‐in‐human safety and feasibility pilot study involving the PS3 System. Methods and Results: The primary objective of this first‐in‐human study was to evaluate the safety and feasibility of acute percutaneous septal‐lateral shortening by using the PS3 System in patients immediately prior to clinically‐indicated surgical mitral valve repair. Two patients were enrolled. Patient One had severe aortic insufficiency with moderate functional mitral regurgitation. The PS3 System reduced the MR grade from 2+ to 1+ with a decrease in the mean septal‐lateral systolic (SLS) dimension from 38 to 27 mm (29% reduction). Patient Two had severe ischemic mitral regurgitation in the setting of severe multi‐vessel disease and prior infero‐posterior infarct. MR grade was reduced from 3+ to 1+ with a decrease in the mean SLS dimension from 36 to 25mm (31% reduction). There were no procedural complications and both patients proceeded to pre‐planned cardiac surgery, where the devices were explanted under direct visualization. Conclusions: The PS3 System has been safely translated from the preclinical setting to first‐in‐human implantation. Both patients studied experienced a reduction in MR after device implantation, with significant SLS shortening. Further clinical trials will be needed to assess long‐term efficacy and durability.Keywords
This publication has 14 references indexed in Scilit:
- Percutaneous Septal Sinus ShorteningCirculation, 2006
- Does septal-lateral annular cinching work for chronic ischemic mitral regurgitation?The Journal of Thoracic and Cardiovascular Surgery, 2004
- Septal-lateral annular cinching abolishes acute ischemic mitral regurgitationThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Pathogenesis of Mitral Regurgitation in Tachycardia-Induced CardiomyopathyCirculation, 2001
- Intermediate-Term Outcome Of Mitral Reconstruction In CardiomyopathyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Insights From Three-Dimensional Echocardiography Into the Mechanism of Functional Mitral RegurgitationCell Metabolism, 1997
- On the mechanism of functional mitral regurgitationThe American Journal of Cardiology, 1993
- Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failureJournal of the American College of Cardiology, 1992
- Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation.Cell Metabolism, 1983
- Cardiac valve surgery—the “French correction”The Journal of Thoracic and Cardiovascular Surgery, 1983